Asia Pacific Pet Therapeutic Diet Market size to cross USD 1.7 Billion by 2034

Published Date: January 1970

Asia Pacific Pet Therapeutic Diet Market size to cross USD 1.7 Billion by 2034

Published Date: January 1970

Selbyville, DE. - Asia Pacific pet therapeutic diet market was estimated at USD 798.4 million in 2024 and is expected to grow from USD 850.3 million in 2025 to USD 1.7 billion by 2034, at a CAGR of 8.2%, according to the latest report published by Global Market Insights Inc.   

Urbanization in countries like China, India, and Southeast Asian nations is leading to a rise in pet ownership. As more people adopt pets in cities, there’s a growing demand for specialized diets to manage lifestyle-related health conditions in pets.  

Key Insights:

Market Size & Growth:

  • 2024 Market Size: USD 798.4 million
  • 2025 Market Size: USD 850.3 million
  • 2034 Forecast Market Size: USD 1.7 billion
  • CAGR (2025–2034): 8.2%  
Regional Insights:
  • Largest Market: China
  • Fastest Growing Market: India
  • Emerging Countries: Australia, South Korea, Indonesia, Thailand, Vietnam  

Key Growth Drivers:

  1. Rising awareness of pet health and wellness: Pet owners are becoming more educated about pet nutrition and the importance of disease prevention.  
  2. Growth of the veterinary services sector: As access to veterinary services expands across the Asia Pacific, more pets are being diagnosed with chronic or age-related conditions.  
  3. Aging pet population: With improvements in veterinary care and nutrition, pets are living longer.  
  4. Premiumization of pet products: Consumers in the Asia Pacific region are increasingly willing to spend more on their pets, mirroring trends seen in human health and wellness.  
  5. Expansion of retail and E-commerce channels: The availability of therapeutic pet food through online platforms and specialty pet stores is making it more accessible, even in emerging markets.  

Key Players:

  • Purina PetCare (Nestle SA) led the market with over 28.6% share in 2024.  
  • Some of the top players in this market include Amcor, Gerresheimer, AptarGroup, West Pharmaceutical Services, and Schott, which together held a 65.1% share in 2024.  
Key Challenges:
  1. Low awareness among pet owners: While awareness is growing, many pet owners, especially in rural and emerging markets, still lack understanding of the importance of therapeutic diets.  
  2. High cost of therapeutic diets: Specialized diets are significantly more expensive than regular pet food.  
  3. Limited veterinary access in rural areas: Veterinary clinics and professionals are often concentrated in urban centers.  
  4. Regulatory and labeling inconsistencies: Different countries in the region have varying regulations for pet food ingredients, labeling, and health claims.  
  5. Fragmented distribution networks: In some Asia Pacific markets, the distribution of pet products is still fragmented.  

Browse key industry insights spread across 118 pages with 87 market data tables and figures from the report, “Asia Pacific Pet Therapeutic Diet Market - By Product Type, By Animal Type, By Health Condition, By Distribution Channel - Forecast 2025 - 2034” in detail, along with the table of contents:  

https://www.gminsights.com/industry-analysis/asia-pacific-pet-therapeutic-diet-market  

Rising Adoption of Dry Food

The dry food segment held a notable share in 2024, driven by its convenience, longer shelf life, and cost-effectiveness. Consumers find dry therapeutic food easier to store and measure, making it a preferred choice for daily feeding routines. Veterinary-recommended formulations for conditions like renal support, gastrointestinal health, and weight management are widely available in dry formats, allowing brands to reach a broader customer base. As urban pet ownership rises, demand for easily accessible, health-specific dry pet food products is expected to contribute significantly.  

Rising Prevalence of Dogs

The dogs segment in the Asia Pacific pet therapeutic diet market generated a significant share in 2024, driven by their increasing popularity as companion animals across both urban and semi-urban regions. Dog owners are more likely to seek specialized nutrition plans for their pets, particularly chronic issues such as joint disorders, obesity, and skin allergies. With the growing influence of veterinary professionals and pet wellness trends, more dog owners are turning to prescription-based diets for preventive care.  

Weight Management to Gain Traction

The weight management segment held sizeable growth in 2024 as obesity among pets becomes a widespread concern across the Asia Pacific region. Rising calorie intake and reduced physical activity, especially among indoor pets, have triggered health risks that necessitate dietary intervention. Therapeutic diets focused on weight control offer low-fat, high-fiber formulations to support metabolic health without compromising on taste or nutrition. Brands are capitalizing on this by introducing vet-formulated options specifically designed to reduce weight-related complications.  

Regional Insights

China to Emerge as a Lucrative Region

China pet therapeutic diet market held a significant share in 2024, driven by rapid urbanization, rising disposable incomes, and a shift toward pet humanization. The market is seeing a steady rise in demand for condition-specific diets prescribed by veterinary professionals. Local and international players alike are expanding their distribution networks and product portfolios to cater to this demand.  

Major players in the Asia Pacific pet therapeutic diet market are JustFoodForDogs, Hill's Pet Nutrition (Colgate-Palmolive), VNG, Farmina Pet Foods, Husse, Blue Buffalo (General Mills), Stella and Chewy’s, Eden Holistic Pet Foods, Mars, Incorporated, Ziwi Pets, Virbac, Drools Pet Food, Open Farm, Diamond Pet Foods (Schell & Kampeter, Inc.), EmerAid, Purina PetCare (Nestle SA).  

To strengthen their presence in the Asia Pacific pet therapeutic diet market, companies are deploying a range of targeted strategies. Leading brands are investing heavily in R&D to develop science-backed, condition-specific formulations that align with regional dietary preferences and veterinary guidelines. Strategic partnerships with veterinary clinics and hospitals enable companies to directly reach pet owners through professional recommendations. Additionally, many are leveraging digital platforms and e-commerce to expand their customer base beyond metropolitan areas.  

Authors:
 Mariam Faizullabhoy, Gauri Wani
Top